
Brijmohan Sharma
About Brijmohan Sharma
Data last updated:
Brijmohan Sharma has 23 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Omni-Protech Drugs Private Limited and Avet Lifesciences Private Limited. Formerly with 4 companies, such as Shrisiddhi Management Consultants Private Limited and Icmai Management Accounting Research Foundation. Engaged in Technology, General Business.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 20 Jul 2003 | 1993 | Active | |
| Director | 06 Sep 2021 | 2020 | Active | |
| Director | 18 Jan 2016 | 2006 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 25 Sep 2007 | 2007 | Active | |
| Director | 04 Sep 2009 | 2009 | Active | |
| Director | 19 Sep 2011 | 1976 | Active | |
| Whole-Time Director | 22 Mar 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brijmohan Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brijmohan Sharma
Brijmohan Sharma has 23 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Omni-Protech Drugs Private Limited and Avet Lifesciences Private Limited. Formerly with 4 companies, such as Shrisiddhi Management Consultants Private Limited and Icmai Management Accounting Research Foundation. Engaged in Technology, General Business.
Brijmohan Sharma is associated with 3 companies as Director and Whole-Time Director.
Brijmohan Sharma has expertise in Technology, General Business.
Brijmohan Sharma has 23 years in corporate governance.